Auto-Immunity Highlights最新文献

{"title":"Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based survey.","authors":"Chelsea Bentow,&nbsp;Marvin J Fritzler,&nbsp;Eckart Mummert,&nbsp;Michael Mahler","doi":"10.1007/s13317-016-0081-2","DOIUrl":"https://doi.org/10.1007/s13317-016-0081-2","url":null,"abstract":"<p><strong>Purpose: </strong>The dense fine speckled (DFS) pattern as detected by indirect immunofluorescence (IIF) on HEp-2 cells has been associated with several inflammatory diseases but is most commonly observed in individuals that do not have an antinuclear antibody (ANA)-associated rheumatic disease and even in apparently healthy individuals. Consequently, the accurate identification and correct reporting of this IIF pattern is of utmost importance and accordingly has been recognized by several international study groups for the detection of ANA. Furthermore, the DFS IIF pattern has recently been recommended as a competency level recognition pattern by the International Consensus on Antinuclear Antibody (ANA) Pattern (ICAP, http://www.anapatterns.org/ ) Committee. The objective of this study was to use an internet-based survey to assess how accurately the DFS IIF pattern was recognized by experienced technologists.</p><p><strong>Methods: </strong>High-resolution digital IIF images were captured using the automated IIF NOVA View instrument (Inova Diagnostics, San Diego, CA). Ten images were posted in an anonymous, international, internet-based interpretive survey. Two hundred and thirty IIF technologists were invited to participate. Four of the images in the survey were from previously characterized serum samples with classical ANA IIF patterns (nucleolar, centromere, homogeneous, and speckled) and two of the images were from samples with a DFS IIF ANA pattern and isolated anti-DFS70 antibodies as determined by a chemiluminescence immunoassay. The remaining four images were from sera with the classic IIF ANA patterns referred to above and mixed with a monospecific anti-DFS70-positive sample. The survey included multiple choice selections: homogeneous, DFS, centromere, nucleolar, speckled, other, or unrecognizable.</p><p><strong>Results: </strong>125 of the 230 participants who completed the survey had diverse levels of experience in IIF pattern recognition on HEp-2 cells ranging from <1 year to >10 years of experience (average >10 years). Participants had a high concordance in correctly classifying the classical ANA IIF patterns: ranging from 95.2 % for centromere to 74.4 % for nucleolar patterns. The unmixed DFS pattern was recognized with significantly lower accuracy (~50 %; p < 0.05). However, less than 10 % correctly identified mixed patterns derived from the sera containing both clinically relevant ANA and anti-DFS70 antibodies.</p><p><strong>Conclusions: </strong>Recognizing the DFS ANA IIF pattern and mixed IIF patterns composed of DFS + clinically relevant ANA patterns poses a significant challenge. Consequently, it seems imperative that DFS-specific immunoassays should be used to confirm the presence of anti-DFS70 antibodies before definitive results are reported to physicians.</p>","PeriodicalId":8655,"journal":{"name":"Auto-Immunity Highlights","volume":"7 1","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13317-016-0081-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34652851","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics.","authors":"Elio Tonutti,&nbsp;Nicola Bizzaro,&nbsp;Gabriella Morozzi,&nbsp;Antonella Radice,&nbsp;Luigi Cinquanta,&nbsp;Danilo Villalta,&nbsp;Renato Tozzoli,&nbsp;Marilina Tampoia,&nbsp;Brunetta Porcelli,&nbsp;Martina Fabris,&nbsp;Ignazio Brusca,&nbsp;Maria Grazia Alessio,&nbsp;Giuseppina Barberio,&nbsp;Maria Concetta Sorrentino,&nbsp;Antonio Antico,&nbsp;Danila Bassetti,&nbsp;Desré Ethel Fontana,&nbsp;Tiziana Imbastaro,&nbsp;Daniela Visentini,&nbsp;Giampaola Pesce,&nbsp;Marcello Bagnasco","doi":"10.1007/s13317-016-0080-3","DOIUrl":"https://doi.org/10.1007/s13317-016-0080-3","url":null,"abstract":"<p><p>Reflex tests are widely used in clinical laboratories, for example, to diagnose thyroid disorders or in the follow-up of prostate cancer. Reflex tests for antinuclear antibodies (ANA) have recently gained attention as a way to improve appropriateness in the immunological diagnosis of autoimmune rheumatic diseases and avoid waste of resources. However, the ANA-reflex test is not as simple as other consolidated reflex tests (the TSH-reflex tests or the PSA-reflex tests) because of the intrinsic complexity of the ANA test performed by the indirect immunofluorescence method on cellular substrates. The wide heterogeneity of the ANA patterns, which need correct interpretation, and the subsequent choice of the most appropriate confirmatory test (ANA subserology), which depend on the pattern feature and on clinical information, hinder any informatics automation, and require the pathologist's intervention. In this review, the Study Group on Autoimmune Diseases of the Italian Society of Clinical Pathology and Laboratory Medicine provides some indications on the configuration of the ANA-reflex test, using two different approaches depending on whether clinical information is available or not. We further give some suggestions on how to report results of the ANA-reflex test. </p>","PeriodicalId":8655,"journal":{"name":"Auto-Immunity Highlights","volume":"7 1","pages":"9"},"PeriodicalIF":0.0,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13317-016-0080-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34576778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Deciphering the role of DNA methylation in multiple sclerosis: emerging issues.","authors":"Maria Sokratous,&nbsp;Efthimios Dardiotis,&nbsp;Zisis Tsouris,&nbsp;Eleni Bellou,&nbsp;Amalia Michalopoulou,&nbsp;Vasileios Siokas,&nbsp;Stylianos Arseniou,&nbsp;Tzeni Stamati,&nbsp;Georgios Tsivgoulis,&nbsp;Dimitrios Bogdanos,&nbsp;Georgios M Hadjigeorgiou","doi":"10.1007/s13317-016-0084-z","DOIUrl":"https://doi.org/10.1007/s13317-016-0084-z","url":null,"abstract":"<p><p>Multiple sclerosis (MS) is an autoimmune inflammatory and neurodegenerative disease of the central nervous system that involves several not yet fully elucidated pathophysiologic mechanisms. There is increasing evidence that epigenetic modifications at level of DNA bases, histones, and micro-RNAs may confer risk for MS. DNA methylation seems to have a prominent role in the epigenetics of MS, as aberrant methylation in the promoter regions across genome may underlie several processes involved in the initiation and development of MS. In the present review, we discuss current understanding regarding the role of DNA methylation in MS, possible therapeutic implications and future emerging issues. </p>","PeriodicalId":8655,"journal":{"name":"Auto-Immunity Highlights","volume":"7 1","pages":"12"},"PeriodicalIF":0.0,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13317-016-0084-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34728509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Measurement of anti-DFS70 antibodies in patients with ANA-associated autoimmune rheumatic diseases suspicion is cost-effective.","authors":"Simón Gundín,&nbsp;Juan Irure-Ventura,&nbsp;Esther Asensio,&nbsp;David Ramos,&nbsp;Michael Mahler,&nbsp;Victor Martínez-Taboada,&nbsp;Marcos López-Hoyos","doi":"10.1007/s13317-016-0082-1","DOIUrl":"https://doi.org/10.1007/s13317-016-0082-1","url":null,"abstract":"<p><p>The presence of antinuclear antibodies (ANA) is associated with a wide range of ANA-associated autoimmune rheumatic diseases (AARD). The most commonly method used for the detection of ANA is indirect immunofluorescence (IIF) on HEp-2 cells. This method is very sensitive but unspecific. As a consequence, ANA testing on HEp-2 substrates outside a proper clinical specialist framework may lead to inappropriate referrals to tertiary care specialists and, worst case inappropriate and potentially toxic therapy for the patient. Among ANA, isolated anti-DFS70 antibodies represent a potentially important biomarker that can be clinically used to discriminate AARD from non-AARD patients in ANA IIF positive individuals. Therefore, their presence may avoid unnecessary follow-up testing and referrals. In our study, we investigated if the implementation of a new ANA workup algorithm allowing for the identification of anti-DFS70 antibodies is cost-effective through the reduction of both unnecessary follow-up testing and outpatient clinic visits generated by the clinical suspicion of a potential AARD. None of the 181 patients included with a positive monospecific anti-DFS70 antibody result developed SARD during the follow-up period of 10 years. The reduction in number of tests after ANA and anti-DFS70 positive results was significant for anti-ENA (230 vs. 114 tests; p < 0.001) and anti-dsDNA antibodies (448 vs. 114 tests; p < 0.001). In addition, the outpatient clinic visits decreased by 70 % (p < 0.001). In total, the adoption of the new algorithm including anti-DFS70 antibody testing resulted in a cost saving of 60869.53 € for this pilot study. In conclusion, the use of anti-DFS70 antibodies was clearly cost-efficient in our setting. </p>","PeriodicalId":8655,"journal":{"name":"Auto-Immunity Highlights","volume":"7 1","pages":"10"},"PeriodicalIF":0.0,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13317-016-0082-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34326597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reactive oxygen species in organ-specific autoimmunity.","authors":"Giulia Di Dalmazi,&nbsp;Jason Hirshberg,&nbsp;Daniel Lyle,&nbsp;Joudeh B Freij,&nbsp;Patrizio Caturegli","doi":"10.1007/s13317-016-0083-0","DOIUrl":"https://doi.org/10.1007/s13317-016-0083-0","url":null,"abstract":"<p><p>Reactive oxygen species (ROS) have been extensively studied in the induction of inflammation and tissue damage, especially as it relates to aging. In more recent years, ROS have been implicated in the pathogenesis of autoimmune diseases. Here, ROS accumulation leads to apoptosis and autoantigen structural changes that result in novel specificities. ROS have been implicated not only in the initiation of the autoimmune response but also in its amplification and spreading to novel epitopes, through the unmasking of cryptic determinants. This review will examine the contribution of ROS to the pathogenesis of four organ specific autoimmune diseases (Hashimoto thyroiditis, inflammatory bowel disease, multiple sclerosis, and vitiligo), and compare it to that of a better characterized systemic autoimmune disease (rheumatoid arthritis). It will also discuss tobacco smoking as an environmental factor endowed with both pro-oxidant and anti-oxidant properties, thus capable of differentially modulating the autoimmune response. </p>","PeriodicalId":8655,"journal":{"name":"Auto-Immunity Highlights","volume":"7 1","pages":"11"},"PeriodicalIF":0.0,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13317-016-0083-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34732585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An unusual association of three autoimmune disorders: celiac disease, systemic lupus erythematosus and Hashimoto's thyroiditis.","authors":"Viera Boccuti,&nbsp;Antonio Perrone,&nbsp;Alessia D'Introno,&nbsp;Anna Campobasso,&nbsp;Moris Sangineto,&nbsp;Carlo Sabbà","doi":"10.1007/s13317-016-0079-9","DOIUrl":"https://doi.org/10.1007/s13317-016-0079-9","url":null,"abstract":"<p><p>Autoimmune disorders are known to be more frequent in women and often associated each others, but it is rare to see multiple autoimmune diseases in a single patient. Recently, the concept of multiple autoimmune syndrome has been introduced to describe patients with at least three autoimmune diseases. We describe a case of a young man with a clinical history of psychiatric symptoms and celiac disease (CD) who was diagnosed to have other two autoimmune disorders: systemic lupus erythematosus (SLE) and Hashimoto's thyroiditis. This case is unusual upon different patterns: the rare combination of the three autoimmune diseases, their appearance in a man and the atypical onset of the diseases with psychiatric symptoms likely to be related either to CD or to SLE. </p>","PeriodicalId":8655,"journal":{"name":"Auto-Immunity Highlights","volume":"7 1","pages":"7"},"PeriodicalIF":0.0,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13317-016-0079-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34705403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Detection of autoantibodies to DSF70/LEDGFp75 in Mexican Hispanics using multiple complementary assay platforms","authors":"M. Vázquez-del Mercado, E. Gómez-Bañuelos, R. Navarro-Hernández, O. Pizano-Martínez, A. Saldaña-Millán, E. Chavarría-Avila, L. Gonzalez-Rosas, L. Andrade-Ortega, M. Saavedra, O. Vera-Lastra, L. Jara, G. Medrano-Ramírez, C. Cruz-Reyes, I. García-De La Torre, Marta Escarra-Senmarti, L. Anjos, Anamika Basu, R. Albesa, M. Mahler, C. Casiano","doi":"10.1007/s13317-016-0089-7","DOIUrl":"https://doi.org/10.1007/s13317-016-0089-7","url":null,"abstract":"","PeriodicalId":8655,"journal":{"name":"Auto-Immunity Highlights","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82775454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis","authors":"Sabine L. Kramp, D. Karayev, G. Shen, A. Metzger, R. Morris, E. Karayev, Yvonne Lam, Richard M. Kazdan, G. Pruijn, S. Saschenbrecker, C. Dähnrich, W. Schlumberger","doi":"10.1007/s13317-016-0088-8","DOIUrl":"https://doi.org/10.1007/s13317-016-0088-8","url":null,"abstract":"","PeriodicalId":8655,"journal":{"name":"Auto-Immunity Highlights","volume":"40 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76475626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection","authors":"S. Calise, N. Bizzaro, T. Nguyen, D. Bassetti, B. Porcelli, P. Almi, G. Barberio, G. Pesce, M. Satoh, E. Chan","doi":"10.1007/s13317-016-0087-9","DOIUrl":"https://doi.org/10.1007/s13317-016-0087-9","url":null,"abstract":"","PeriodicalId":8655,"journal":{"name":"Auto-Immunity Highlights","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13317-016-0087-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"53177074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intraepithelial lymphocytes subsets in different forms of celiac disease","authors":"M. Sánchez-Castañón, B. Castro, M. Toca, C. Santacruz, M. Arias-Loste, P. Iruzubieta, J. Crespo, M. López-Hoyos","doi":"10.1007/s13317-016-0085-y","DOIUrl":"https://doi.org/10.1007/s13317-016-0085-y","url":null,"abstract":"","PeriodicalId":8655,"journal":{"name":"Auto-Immunity Highlights","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s13317-016-0085-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"53177037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}